Back to main page

DREAM Module Identification Challenge – Consensus modules

PPI-STRING_Consensus_mod39

Assigned name NA
Network PPI-STRING
Module ID PPI-STRING_Consensus_mod39
Module size 48 genes

Module genes

This module comprises the following genes:

Gene ID Gene Symbol Gene Name
1434

CSE1L chromosome segregation 1 like
285381

DPH3 diphthamide biosynthesis 3
359787

DPPA3 developmental pluripotency associated 3
283450

HECTD4 HECT domain E3 ubiquitin protein ligase 4
51194

IPO11 importin 11
9670

IPO13 importin 13
79711

IPO4 importin 4
3843

IPO5 importin 5
3836

KPNA1 karyopherin subunit alpha 1
3838

KPNA2 karyopherin subunit alpha 2
3839

KPNA3 karyopherin subunit alpha 3
3840

KPNA4 karyopherin subunit alpha 4
3841

KPNA5 karyopherin subunit alpha 5
23633

KPNA6 karyopherin subunit alpha 6
402569

KPNA7 karyopherin subunit alpha 7
3837

KPNB1 karyopherin subunit beta 1
54830

NUP62CL nucleoporin 62 C-terminal like
10204

NUTF2 nuclear transport factor 2
5901

RAN RAN, member RAS oncogene family
5902

RANBP1 RAN binding protein 1
8498

RANBP3 RAN binding protein 3
202151

RANBP3L RAN binding protein 3 like
26953

RANBP6 RAN binding protein 6
29098

RANGRF RAN guanine nucleotide release factor
55213

RCBTB1 RCC1 and BTB domain containing protein 1
1102

RCBTB2 RCC1 and BTB domain containing protein 2
308760

RCC1 RCC1 domain containing 1
91433

RCCD1 RCC1 domain containing 1
400966

RGPD1 RANBP2-like and GRIP domain containing 1
400966

RGPD2 RANBP2-like and GRIP domain containing 1
653489

RGPD3 RANBP2-like and GRIP domain containing 3
285190

RGPD4 RANBP2-like and GRIP domain containing 4
84220

RGPD5 RANBP2-like and GRIP domain containing 5
729540

RGPD6 RANBP2-like and GRIP domain containing 6
727851

RGPD8 RANBP2-like and GRIP domain containing 8
6103

RPGR retinitis pigmentosa GTPase regulator
55197

RPRD1A regulation of nuclear pre-mRNA domain containing 1A
58490

RPRD1B regulation of nuclear pre-mRNA domain containing 1B
26297

SERGEF secretion regulating guanine nucleotide exchange factor
200162

SPAG17 sperm associated antigen 17
9576

SPAG6 sperm associated antigen 6
23306

TMEM194A nuclear envelope integral membrane protein 1
100131211

TMEM194B nuclear envelope integral membrane protein 2
30000

TNPO2 transportin 2
81671

VMP1 vacuole membrane protein 1
81554

WBSCR16 RCC1 like
65249

ZSWIM4 zinc finger SWIM-type containing 4
57643

ZSWIM5 zinc finger SWIM-type containing 5

Functional annotation

Modules were tested for enrichment in functional and pathway annotations using two complementary approaches:
1. To select a small number of specific / non-redundant annotations for each module, a regression-based approach was used;
2. To obtain the complete set of enriched annotations, an extension of Fisher’s exact test that takes annotation bias into account was employed (Wallenius’ non-central hypergeometric distribution).

Most specific annotations for this module

Coeff.1P-value.2Source.3Term.4Class.5
4.02e-01 3.47e-20 GO nuclear import signal receptor activity

molecular_function
3.17e-01 6.15e-43 GO Ran GTPase binding

molecular_function
2.53e-01 4.73e-40 GO NLS-bearing protein import into nucleus

biological_process
1.05e-01 4.77e-15 GO ribosomal protein import into nucleus

biological_process
3.04e-02 7.61e-23 GO nuclear localization sequence binding

molecular_function
2.18e-02 3.32e-04 GO RNA polymerase II, holoenzyme

cellular_component
1.40e-02 3.98e-04 GO negative regulation of protein secretion

biological_process
3.25e-03 6.90e-30 GO nuclear pore

cellular_component

1Regression coefficient

2Fisher’s exact test nominal P-value

3Annotation source (Reactome, GO biological process (BP), molecular function (MF) and cellular component (CC))

4GO category or Reactome pathway

5High-level branch of annotation tree

Gene membership

All enriched annotations

Gene Ontology

P-value1 FDR2 Term
0e+00 0e+00 single-organism nuclear import

0e+00 0e+00 nuclear import

0e+00 0e+00 nuclear transport

0e+00 0e+00 nucleocytoplasmic transport

0e+00 0e+00 protein import into nucleus, translocation

0e+00 0e+00 modulation by virus of host morphology or physiology

0e+00 0e+00 protein localization to nucleus

0e+00 0e+00 ribosomal protein import into nucleus

0e+00 0e+00 protein targeting

0e+00 0e+00 protein import into nucleus

0e+00 0e+00 NLS-bearing protein import into nucleus

0e+00 0e+00 protein localization to organelle

0e+00 0e+00 establishment of protein localization to organelle

0e+00 0e+00 modulation by virus of host process

0e+00 0e+00 protein import

0e+00 0e+00 nuclear envelope

0e+00 0e+00 nuclear pore

0e+00 0e+00 peptide transporter activity

0e+00 0e+00 protein transporter activity

0e+00 0e+00 peptide binding


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Reactome

P-value1 FDR2 Term
3.29e-11 1.24e-08 ANTIVIRAL MECHANISM BY IFN STIMULATED GENES
1.73e-09 4.11e-07 ANTIVIRAL MECHANISM BY IFN STIMULATED GENES
5.13e-09 1.54e-06 HOST INTERACTIONS OF HIV FACTORS
5.07e-08 1.36e-05 INTERFERON SIGNALING
1.39e-07 3.53e-05 HIV INFECTION
4.36e-07 1.04e-04 CYTOKINE SIGNALING IN IMMUNE SYSTEM
6.53e-07 1.17e-04 INTERFERON SIGNALING
1.74e-06 2.92e-04 HOST INTERACTIONS OF HIV FACTORS
7.43e-06 1.14e-03 CYTOKINE SIGNALING IN IMMUNE SYSTEM
1.18e-05 2.23e-03 TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS
2.25e-05 3.18e-03 HIV INFECTION
3.93e-05 6.75e-03 INFLUENZA LIFE CYCLE
6.33e-05 1.03e-02 LATE PHASE OF HIV LIFE CYCLE
1.30e-04 1.97e-02 HIV LIFE CYCLE
2.22e-04 2.61e-02 INFLUENZA LIFE CYCLE
4.66e-04 6.05e-02 APOPTOSIS INDUCED DNA FRAGMENTATION
6.22e-04 6.57e-02 APOPTOSIS INDUCED DNA FRAGMENTATION
1.08e-03 1.08e-01 TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS
1.20e-03 1.18e-01 LATE PHASE OF HIV LIFE CYCLE
1.63e-03 1.55e-01 HIV LIFE CYCLE

11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Mouse mutant phenotypes

P-value1 FDR2 Term
0.00e+00 0.00e+00 elevated level of mitotic sister chromatid exchange

2.66e-12 1.98e-07 decreased tumor latency

7.84e-11 4.42e-06 increased lung carcinoma incidence

1.36e-10 7.46e-06 abnormal rod electrophysiology

9.74e-10 3.76e-05 increased sarcoma incidence

1.02e-09 3.80e-05 abnormal mitosis

1.81e-09 5.70e-05 aneuploidy

6.04e-09 1.68e-04 increased incidence of tumors by chemical induction

1.19e-08 2.91e-04 increased hepatocellular carcinoma incidence

1.30e-08 3.08e-04 abnormal nervous system physiology

1.99e-08 4.11e-04 decreased susceptibility to diet-induced obesity

3.67e-08 6.54e-04 complete prenatal lethality

3.89e-08 6.78e-04 increased tumor incidence

1.34e-07 1.75e-03 impaired glucose tolerance

1.56e-06 1.20e-02 complete embryonic lethality

2.04e-06 1.49e-02 complete preweaning lethality

1.87e-03 1.00e+00 abnormal pulmonary alveolus epithelium morphology

3.75e-03 1.00e+00 abnormal pregnancy

3.75e-03 1.00e+00 absent sperm head

5.61e-03 1.00e+00 neural tube degeneration


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)


Generated on: Thu Aug 30 17:21:35 2018 - R2HTML